13F HOLDINGS REPORT
TCG Crossover Management, LLC
Quarter ended Q3 2024 · Filed November 14, 2024 · Accession 0001214659-24-019064
Total Value
$1.18B
Positions
36
Other Managers
0
Confidential Omitted
No
Holdings (36)
| # | Issuer | Ticker / CUSIP | Shares | Value | % of Filing |
|---|---|---|---|---|---|
| 1 | CG ONCOLOGY, INC. | CGON | 3,670,206 | $138.5M | 11.73% |
| 2 | DYNE THERAPEUTICS, INC | DYN | 2,650,150 | $95.2M | 8.07% |
| 3 | COGENT BIOSCIENCES INC | COGT | 6,964,375 | $75.2M | 6.37% |
| 4 | Abivax SA | AAVXF | 6,056,596 | $69.8M | 5.91% |
| 5 | EDGEWISE THERAPEUTICS, INC. | EWTX | 2,112,984 | $56.4M | 4.78% |
| 6 | SILENCE THERAPEUTICS PLC | SLNCF | 3,033,560 | $55.2M | 4.67% |
| 7 | SAVARA INC. | SVRA | 12,362,205 | $52.4M | 4.44% |
| 8 | KEROS THERAPEUTICS, INC. | KROS | 879,344 | $51.1M | 4.33% |
| 9 | XENCOR INC | XNCR | 2,427,138 | $48.8M | 4.14% |
| 10 | TYRA BIOSCIENCES INC | TYRA | 1,989,103 | $46.8M | 3.96% |
| 11 | STRUCTURE THERAPEUTICS INC | GPCR | 1,063,000 | $46.7M | 3.95% |
| 12 | OCULAR THERAPEUTIX, INC. | OCUL | 5,319,148 | $46.3M | 3.92% |
| 13 | CENTESSA PHARMACEUTICALS PLC | CNTA | 2,890,816 | $46.2M | 3.92% |
| 14 | TOURMALINE BIO INC | 89157D105 | 1,477,593 | $38.0M | 3.22% |
| 15 | THIRD HARMONIC BIO INC | 88427A107 | 2,415,000 | $32.7M | 2.77% |
| 16 | ASTRIA THERAPEUTICS, INC. | 04635X102 | 2,761,861 | $30.4M | 2.58% |
| 17 | MINERALYS THERAPEUTICS, INC. | MLYS | 2,470,265 | $29.9M | 2.53% |
| 18 | KURA ONCOLOGY INC | KURA | 1,423,642 | $27.8M | 2.36% |
| 19 | SOLENO THERAPEUTIVS, INC. | SLNO | 550,000 | $27.8M | 2.35% |
| 20 | COMPASS PATHWAYS PLC | CMPS | 3,858,000 | $24.3M | 2.06% |
| 21 | Disc Medicine, Inc. | IRON | 486,957 | $23.9M | 2.03% |
| 22 | FULCRUM THERAPEUTICS INC | FULC | 5,250,000 | $18.7M | 1.59% |
| 23 | MBX BIOSCIENCES INC | MBX | 650,000 | $16.9M | 1.43% |
| 24 | AMYLYX PHARMACEUTICALS INC | AMLX | 4,643,812 | $15.0M | 1.27% |
| 25 | ADVERUM BIOTECHNOLOGIES, INC. | 00773U207 | 2,008,339 | $14.1M | 1.19% |
| 26 | ENTRADA THERAPEUTICS INC | TRDA | 584,955 | $9.3M | 0.79% |
| 27 | VISTAGEN THERAPEUTICS INC | VTGN | 2,676,580 | $8.1M | 0.68% |
| 28 | TARSUS PHARMACEUTICALS, INC. | TARS | 231,820 | $7.6M | 0.65% |
| 29 | EyePoint Pharmaceuticals, Inc. | EYPT | 922,335 | $7.4M | 0.62% |
| 30 | NEKTAR THERAPEUTICS | NKTR | 4,000,000 | $5.2M | 0.44% |
| 31 | AEROVATE THERAPEUTICS INC | 008064107 | 2,240,809 | $4.7M | 0.40% |
| 32 | AVALO THERAPEUTICS INC | AVTX | 483,000 | $4.6M | 0.39% |
| 33 | KODIAK SCIENCES INC | KOD | 1,008,158 | $2.6M | 0.22% |
| 34 | AN2 Therapeutics, Inc. | ANTX | 1,555,118 | $1.7M | 0.14% |
| 35 | VENTYX BIOSCIENCES, INC | 92332V107 | 316,195 | $689,305 | 0.06% |
| 36 | CABALETTA BIO, INC | CABA | 86,795 | $409,672 | 0.03% |